Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival

Yoichi Fujii, Eiji Sugawara, Kazuhiko Hayashi, Shunji Sano

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Intrathymic (IT) injection of allogenic cells without administration of anti-lymphocyte serum (ALS) in neonatal recipients has induced donor-specific tolerance to subsequent cardiac allografts in rats. This study examines whether similar tactics can be successfully applied to a hamster-to-rat cardiac xenotransplantation model. Lewis neonates on their first day of life underwent IT, subcutaneous (SC), intraperitoneal (IP), or intravenous (IV) injections of 5 × 107 Golden Syrian hamster splenocytes. After six weeks, the rats underwent heterotopic cardiac transplantation of hamster hearts. Cyclophosphamide (CyP) was administered on the day before surgery and postoperatively to suppress antibody-mediated graft rejection. Rats given splenocytes with 80 mg/kg of CyP had the following graft survival times: 8 to 12 days for IT injection (mean, 9.4 days); 5 to 7 days for SC injection (mean, 6.6 days); 4 to 11 days for IP injection (mean, 7.4 days); and 4 to 13 days for IV injection (mean, 7.9 days). Only the extension of graft survival produced by IT injection was statistically significant in comparison with the rats given only CyP treatment (mean, 7.5 days; P <0.05). Thus, it appears that IT injection of xenogenic splenocytes in neonatal recipients with administration of CyP, but without ALS, can prolong xenograft survival. This biological intervention may be most useful in pediatric xenotransplantation when combined with other immunomodulation techniques.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalActa Medica Okayama
Volume52
Issue number2
Publication statusPublished - Apr 1998

Fingerprint

Heterografts
Rats
Cyclophosphamide
Injections
Grafts
Heterologous Transplantation
Lymphocytes
Graft Survival
Subcutaneous Injections
Intraperitoneal Injections
Intravenous Injections
Cricetinae
Heterotopic Transplantation
Pediatrics
Immunomodulation
Mesocricetus
Graft Rejection
Heart Transplantation
Serum
Ambulatory Surgical Procedures

Keywords

  • Intrathymic injection
  • Neonatal tolerance
  • Xenografts

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Fujii, Y., Sugawara, E., Hayashi, K., & Sano, S. (1998). Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival. Acta Medica Okayama, 52(2), 83-88.

Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival. / Fujii, Yoichi; Sugawara, Eiji; Hayashi, Kazuhiko; Sano, Shunji.

In: Acta Medica Okayama, Vol. 52, No. 2, 04.1998, p. 83-88.

Research output: Contribution to journalArticle

Fujii, Y, Sugawara, E, Hayashi, K & Sano, S 1998, 'Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival', Acta Medica Okayama, vol. 52, no. 2, pp. 83-88.
Fujii, Yoichi ; Sugawara, Eiji ; Hayashi, Kazuhiko ; Sano, Shunji. / Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival. In: Acta Medica Okayama. 1998 ; Vol. 52, No. 2. pp. 83-88.
@article{2f2bfb1485d74954b4993c31e48deb9c,
title = "Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival",
abstract = "Intrathymic (IT) injection of allogenic cells without administration of anti-lymphocyte serum (ALS) in neonatal recipients has induced donor-specific tolerance to subsequent cardiac allografts in rats. This study examines whether similar tactics can be successfully applied to a hamster-to-rat cardiac xenotransplantation model. Lewis neonates on their first day of life underwent IT, subcutaneous (SC), intraperitoneal (IP), or intravenous (IV) injections of 5 × 107 Golden Syrian hamster splenocytes. After six weeks, the rats underwent heterotopic cardiac transplantation of hamster hearts. Cyclophosphamide (CyP) was administered on the day before surgery and postoperatively to suppress antibody-mediated graft rejection. Rats given splenocytes with 80 mg/kg of CyP had the following graft survival times: 8 to 12 days for IT injection (mean, 9.4 days); 5 to 7 days for SC injection (mean, 6.6 days); 4 to 11 days for IP injection (mean, 7.4 days); and 4 to 13 days for IV injection (mean, 7.9 days). Only the extension of graft survival produced by IT injection was statistically significant in comparison with the rats given only CyP treatment (mean, 7.5 days; P <0.05). Thus, it appears that IT injection of xenogenic splenocytes in neonatal recipients with administration of CyP, but without ALS, can prolong xenograft survival. This biological intervention may be most useful in pediatric xenotransplantation when combined with other immunomodulation techniques.",
keywords = "Intrathymic injection, Neonatal tolerance, Xenografts",
author = "Yoichi Fujii and Eiji Sugawara and Kazuhiko Hayashi and Shunji Sano",
year = "1998",
month = "4",
language = "English",
volume = "52",
pages = "83--88",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "2",

}

TY - JOUR

T1 - Neonatal Intrathymic Splenocyte Injection Yields Prolonged Cardiac Xenograft Survival

AU - Fujii, Yoichi

AU - Sugawara, Eiji

AU - Hayashi, Kazuhiko

AU - Sano, Shunji

PY - 1998/4

Y1 - 1998/4

N2 - Intrathymic (IT) injection of allogenic cells without administration of anti-lymphocyte serum (ALS) in neonatal recipients has induced donor-specific tolerance to subsequent cardiac allografts in rats. This study examines whether similar tactics can be successfully applied to a hamster-to-rat cardiac xenotransplantation model. Lewis neonates on their first day of life underwent IT, subcutaneous (SC), intraperitoneal (IP), or intravenous (IV) injections of 5 × 107 Golden Syrian hamster splenocytes. After six weeks, the rats underwent heterotopic cardiac transplantation of hamster hearts. Cyclophosphamide (CyP) was administered on the day before surgery and postoperatively to suppress antibody-mediated graft rejection. Rats given splenocytes with 80 mg/kg of CyP had the following graft survival times: 8 to 12 days for IT injection (mean, 9.4 days); 5 to 7 days for SC injection (mean, 6.6 days); 4 to 11 days for IP injection (mean, 7.4 days); and 4 to 13 days for IV injection (mean, 7.9 days). Only the extension of graft survival produced by IT injection was statistically significant in comparison with the rats given only CyP treatment (mean, 7.5 days; P <0.05). Thus, it appears that IT injection of xenogenic splenocytes in neonatal recipients with administration of CyP, but without ALS, can prolong xenograft survival. This biological intervention may be most useful in pediatric xenotransplantation when combined with other immunomodulation techniques.

AB - Intrathymic (IT) injection of allogenic cells without administration of anti-lymphocyte serum (ALS) in neonatal recipients has induced donor-specific tolerance to subsequent cardiac allografts in rats. This study examines whether similar tactics can be successfully applied to a hamster-to-rat cardiac xenotransplantation model. Lewis neonates on their first day of life underwent IT, subcutaneous (SC), intraperitoneal (IP), or intravenous (IV) injections of 5 × 107 Golden Syrian hamster splenocytes. After six weeks, the rats underwent heterotopic cardiac transplantation of hamster hearts. Cyclophosphamide (CyP) was administered on the day before surgery and postoperatively to suppress antibody-mediated graft rejection. Rats given splenocytes with 80 mg/kg of CyP had the following graft survival times: 8 to 12 days for IT injection (mean, 9.4 days); 5 to 7 days for SC injection (mean, 6.6 days); 4 to 11 days for IP injection (mean, 7.4 days); and 4 to 13 days for IV injection (mean, 7.9 days). Only the extension of graft survival produced by IT injection was statistically significant in comparison with the rats given only CyP treatment (mean, 7.5 days; P <0.05). Thus, it appears that IT injection of xenogenic splenocytes in neonatal recipients with administration of CyP, but without ALS, can prolong xenograft survival. This biological intervention may be most useful in pediatric xenotransplantation when combined with other immunomodulation techniques.

KW - Intrathymic injection

KW - Neonatal tolerance

KW - Xenografts

UR - http://www.scopus.com/inward/record.url?scp=0032043069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032043069&partnerID=8YFLogxK

M3 - Article

C2 - 9588223

AN - SCOPUS:0032043069

VL - 52

SP - 83

EP - 88

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 2

ER -